A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
Clinical trial NCT02451696 · COMPLETED
Trial details
- NCT number
- NCT02451696
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2017-12-08
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.